Results 41 to 50 of about 167,013,277 (277)

12th International Conference on Biosystems Engineering 2021 : Book of abstracts : May 5-7 2021 in Tartu, Estonia [PDF]

open access: yes, 2021
Book of Abstracts. 12th International Conference on Biosystems Engineering 2021, May 5–7, 2021 Tartu, Estonia.
Estonian University of Life Sciences
core   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld   +5 more
wiley   +1 more source

7th International Conference on Biosystems Engineering 2016 : Book of Abstracts : 12-13 May 2016 [PDF]

open access: yes, 2016
Full textBook of Abstracts. 7th International Conference on Biosystems Engineering 2016, May 12–13, 2016 Tartu, Estonia.
Estonian University of Life Sciences
core   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

8th International Conference on Biosystems Engineering 2017 : Book of Abstracts : 11-13 May 2017 [PDF]

open access: yes, 2017
Full textBook of Abstracts. 8th International Conference on Biosystems Engineering 2017, May 11–13, 2017 Tartu, Estonia.
Estonian University of Life Sciences
core   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Proceedings of the first Combivet and Baltic Society of Extracellular Vesicles joint conference 2022 : 30th September & 1st of October, 2022 [PDF]

open access: yes, 2022
About COMBIVET & BALTIC SOCIETY OF EXTRACELLULAR VESCILES JOINT CONFERENCE 2022. The Combivet and Baltic Society of Extracellular Vesicles (BSEV) Joint Conference is organized by the COMBIVET ERA Chair of Comparative Medicine in the Institute of ...
Estonian University of Life Sciences
core   +1 more source

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

Introducing limits of confidentiality in real-life consultations: psychologist-driven or client-centred?

open access: yes, 2010
The Australian Psychological Society Code of Ethics explicitly states that clients are to be informed about the legal limits of confidentiality prior to engaging in any psychological relationship. Maintaining and respecting client confidentiality is also
Lamont-Mills, Andrea   +1 more
core   +1 more source

Real-Life Advantages and Limits of Baricitinib for the Late Treatment of Adults Hospitalized with COVID-19

open access: yesBioMed, 2023
Baricitinib, a reversible Janus-associated kinase-inhibitor, is approved for treating COVID-19, combined with Dexamethasone and, eventually, with Remdesivir (RDV).
Mariacristina Poliseno   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy